Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

33%

2 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

Phase 3

2(66.7%)

N/A

1(33.3%)

3Total

Phase 3(2)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT05003817Phase 3Active Not Recruiting

Controlled Trial of High-risk Coronary Intervention With Percutaneous Left Ventricular Unloading

Role: collaborator

NCT03188796Phase 3Recruiting

The VITDALIZE Study: Effect of High-dose Vitamin D3 on 28-day Mortality in Adult Critically Ill Patients

Role: collaborator

NCT01889810Not ApplicableCompleted

Effect of Vitamin D3 Supplementation on Insulin Resistance- The DIR Study

Role: collaborator

NCT05014477Unknown

Therapy Strategies After LAA Occluder Device Embolization

Role: collaborator

NCT04031274Unknown

Transcatheter Treatment for Combined Aortic and Mitral Valve Disease. The Aortic+Mitral TRAnsCatheter (AMTRAC) Valve Registry

Role: collaborator

NCT00357812Completed

The Efficacy of Two Potential Diagnostic Assays for Herpes Simplex Keratitis (HSK)

Role: collaborator

All 6 trials loaded